dc.contributor.author
Ashurko, Igor
dc.contributor.author
Tarasenko, Svetlana
dc.contributor.author
Magdalyanova, Mary
dc.contributor.author
Bokareva, Svetlana
dc.contributor.author
Balyasin, Maxim
dc.contributor.author
Galyas, Anna
dc.contributor.author
Khamidova, Marina
dc.contributor.author
Zhornik, Mariia
dc.contributor.author
Unkovskiy, Alexey
dc.date.accessioned
2025-09-23T13:14:43Z
dc.date.available
2025-09-23T13:14:43Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/49499
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-49221
dc.description.abstract
Objective
The gold standard for a soft tissue augmentation around implants is a subepithelial connective tissue graft (CTG), but the xenogeneic collagen matrices (XCM) started to be used as an alternative. This systematic review aimed to assess the effectiveness XCM in comparison to CTG for the increasing the thickness of the soft tissue around implants.
Data
All studies included at least two parallel groups comparing the use of CTG and XCM with a minimum follow-up of 3 months. As the primary outcome, the amount of soft tissue thickness gain after soft tissue augmentation with XCM or CTG was assessed. Secondary outcomes were clinical and patient-related outcomes; evaluation of aesthetic outcomes, patient-reported outcomes measures (PROMs) and complications. Eligible studies were selected based on the inclusion criteria. Meta-analysis was applied whenever possible. The quality of the evidence of studies including in meta-analysis was assessed using the GRADE approach.
Source
A systematic literature search up to January 2022 was conducted using the following electronic databases: PubMed (MEDLINE), Scopus, Cochrane Library, LILACS, eLIBRARY.RU. Unpublished researches, the gray literature, nonprofit reports, government studies and other materials were reviewed electronically using an EASY search. An additional manual search was carried out in November 2022.
Study selection
Of the 1376 articles from the initial search, 8 randomized controlled trials (RCTs) (306 patients and 325 implants) were included in this systematic review, and 7 studies were part of the meta-analysis. Meta-analysis revealed that XCM is less effective than the CTG in increasing soft tissue thickness around dental implants. However, XCM also provides soft tissue thickness gain and can be recommended for use in various clinical situations.
Clinical significance
Previous systematic reviews and meta-analyses have shown that autologous grafts are more effective than collagen matrices in increasing soft tissue thickness, however, the latter can be used as an alternative. Studies included in previous systematic reviews varied in design, which could lead to limitations. The present systematic review and meta-analysis includes for the first time only randomized controlled clinical trials with collagen matrix of xenogeneic origin in the test group. Tight eligibility criteria were established, and the main parameter studied was soft tissue thickness. It was found that xenogeneic collagen matrix is effective for increasing soft tissue thickness around dental implants, however, the results obtained using an autogenous connective tissue graft are superior.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
dental implant
en
dc.subject
connective tissue graft
en
dc.subject
subepithelial connective tissue graft
en
dc.subject
collagen matrix
en
dc.subject
soft tissue augmentation
en
dc.subject
thickness increasing
en
dc.subject
systematic review
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Comparative analysis of xenogeneic collagen matrix and autogenous subepithelial connective tissue graft to increase soft tissue volume around dental implants: a systematic review and meta-analysis
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
741
dcterms.bibliographicCitation.doi
10.1186/s12903-023-03475-0
dcterms.bibliographicCitation.journaltitle
BMC Oral Health
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
23
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
37817128
dcterms.isPartOf.eissn
1472-6831